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A B S T R A C T
The interaction of nanoparticles with living cells is becoming one of the urgent areas of collaborative research in
materials science and biology. Previously, we showed that nanoparticles have promising anti-Toxoplasma gondii
properties. Meanwhile, Toxoplasma gondii has been shown to avert apoptosis in host cells whereas nanoparticles
have been implicated for apoptotic tendency. Therefore, in the present study, we assessed the in vitro apoptotic
properties of inorganic nanoparticles in the absence or presence of Toxoplasma infection and/or small molecules
used as metabolic modulators. Results showed that inorganic nanoparticles dose-dependently caused cellular
apoptosis. However, in the presence of infection by Toxoplasma gondii, nanoparticles-induced cellular apoptosis
was not mitigated. Likewise, use of several small molecules (anti-metabolites) as metabolic modulators either
mildly or nearly failed to abate cellular apoptosis by nanoparticles. Taken together, our ﬁndings do not only
conﬁrm the apoptotic potential of inorganic nanoparticles but show evidence that cellular apoptosis by inorganic
nanoparticles of gold and silver might not be susceptible to modulation by Toxoplasma gondii infection. The
ﬁndings are new and contribute to deepen our understanding of the cellular interaction of nanoparticles.
1. Introduction
One of the relevant and recent advances in material science is the
increasing application of nanoparticles (NPs) to transform diverse ﬁelds
of biomedical science (Adeyemi et al., 2017a). For example, over the
past two decades, NPs have been gaining popularity for their usage in
drug delivery, therapeutics, diagnostics among others (Adeyemi and
Sulaiman, 2015). Among the inorganic NPs with biological signiﬁcance
are silver nanoparticles (AgNPs), gold nanoparticles (AuNPs) and pla-
tinum nanoparticles (PtNPs). AgNPs have been implicated for cytotoxic
eﬃcacy applicable in cancer therapy (Azizi et al., 2017). AuNPs are
inert and biocompatible and these have been applied as theranostics as
well as for phototherapy (Moses et al., 2016; Rieznichenko et al., 2012)
while PtNPs are noted for antioxidant properties that mimic catalase
and superoxide dismutase (Sulaiman et al., 2015; Adeyemi et al.,
2018a). As a further testament of the increasing popularity of NPs for
biomedical applications, the potential of NPs against Toxoplasma gondii
infection was recently reported (Adeyemi et al., 2017a; Adeyemi et al.,
2017b). In these studies, AgNPs, AuNPs, and PtNPs, exhibited anti-
parasitic potential which in part was mediated through modulation of
host cellular processes such as the downregulation of hypoxia inducing
factor 1 protein (HIF-1α) and activation of kynurenine pathway. In-
terestingly, NPs and T. gondii aﬀect similar cellular targets such as
hypoxia inducing factor 1 (HIF-1α) and tryptophan pathway, particu-
larly indoleamine 2,3-dioxygenase (IDO; rate limiting enzyme in the
degradation of tryptophan to form kynurenine) (Blader and Saeji, 2009;
Adeyemi et al., 2017b; Wiley et al., 2010; Spear et al., 2006;
Zinkernagel et al., 2007).
Perhaps, there is a growing need to further our understanding of
cellular interactions by NPs. These investigations are warranted if we
consider some emerging facts; for example, the anti-T. gondii potential
of inorganic NPs of silver, gold and platinum has been linked capacity
to modulate cellular processes such as the metabolism of tryptophan as
well as hypoxia in human foreskin ﬁbroblast (HFF) cells (Adeyemi
et al., 2017a, 2017b). Additionally, investigations have shown that NPs
including silver and gold nanoparticles are capable of causing apoptosis
in a variety of cell types (Selim and Hendi, 2012; Satapathy et al.,
2013). On the other hand, T. gondii infection has capacity to modulate
several host cellular processes in order to aid unhindered growth and
replication (Blader and Saeji, 2009; Zinkernagel et al., 2007). In
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particular, T. gondii infection can protect diﬀerent cell types from
apoptosis induced by a variety of pro-apoptotic treatments (Lüder and
Gross, 2005; Goebel et al., 2001). Therefore, in the present study we
sought to determine how the apoptotic property of NPs are aﬀected in
the presence of T. gondii infection and other metabolic modulators such
as L-tryptophan, cobalt (II) chloride (CoCl2), 1-Methyl-D-tryptophan
(DMT), 3-(5’-Hydroxymethyl-2′-furyl)-1-benzyl indazole (YC-1), trolox
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) and (± )
3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[(phenylmethyl)amino]-2H-
naphtho[2,3-b]pyran-5,10-dione (a naphthoquinone derivative – NPQ).
All of these metabolic modulators have been demonstrated to either
enhance or restrict the growth of T. gondii elsewhere (Adeyemi et al.,
2017b).
Fig. 1. Cellular apoptosis after 24 h treatment; [A] Nanoparticles (NPs) [B] Amino-Nanoparticles (amino-NPs) [C] Nanoparticles (NPs) plus Trolox [D] Amino-
Nanoparticles (amino-NPs) plus Trolox. Data are presented as mean of triplicates± standard error of mean (SEM). The experiment was performed in triplicate and
repeated three times independently. α is signiﬁcant at p < .05, β at p < .001 and γ at p < 0.0001versus negative control.
Fig. 2. Cellular apoptosis with time kinetics; [A] Treatment with nanoparticles (NPs) [B] Treatment with amino-nanoparticles (amino-NPs). Data are presented as
mean of triplicates± standard error of mean (SEM). The experiment was performed in triplicate and repeated three times independently. β is signiﬁcant at p < .001
and γ at p < 0.0001versus negative control.
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2. Materials and methods
2.1. Materials and chemical reagents
Nanoparticles (NPs) with diameter size range of 5–40 nm, including
silver (AgNP), gold (AuNP), platinum (PtNP) and amino-NPs (silver-
tryptophan - AgNPTRP and gold-tryptophan - AuNPTRP) were gifted by
Global Infection Unit, NRCPD, Obihiro University of Agriculture &
Veterinary Medicine, Obihiro, Japan. Their synthesis and character-
ization have been reported elsewhere (Adeyemi et al., 2018b). The NPs
were reconstituted in fresh culture medium prior to each use. L-tryp-
tophan, L-kynurenine, cobalt (II) chloride (CoCl2), 4-(dimethylamino)
benzaldehyde, 1-Methyl-D-tryptophan (DMT), and 3-(5’-Hydro-
xymethyl-2′-furyl)-1-benzyl indazole (YC-1) were obtained from Sigma-
Aldrich. Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic
acid) was a product of Wako Pure Chemicals (Osaka, Japan); (± )3,4-
dihydro-3-hydroxy-2,2-dimethyl-4-[(phenylmethyl)amino]-2H-
naphtho[2,3-b]pyran-5,10-dione (a naphthoquinone derivative – NPQ)
was obtained from Cayman Chemicals (Ann Arbor, MI, USA). All other
reagents were of analytical grade and used as supplied except stated
otherwise.
2.2. Anti-metabolites
L-tryptophan is an amino acid required for T. gondii growth. CoCl2 is
a chemical inducer of hypoxia while YC-1 is a potent inhibitor of hy-
poxia inducing factor-1 alpha (HIF-1α). Trolox is antioxidant while
(± )3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[(phenylmethyl)amino]-
2H-naphtho[2,3-b]pyran-5,10-dione and 1-Methyl-D-tryptophan are
respectively competitive and non-competitive inhibitors of indoleamine
2,3-dioxygenase (IDO) activity.
2.3. Host cells and parasite strain
Human ﬁbroblast foreskin (HFF; ATCC®, Manassas, VA, USA) cells
were maintained at 37 °C and 5% CO2 atmosphere in culture medium
consisting of Dulbecco's Modiﬁed Eagle's Medium (DMEM; Nissui,
Tokyo, Japan), GlutaMAX™-I (Gibco, Invitrogen, UK), 10% (v/v) fetal
calf serum (FCS; Gibco, Invitrogen, UK), penicillin and streptomycin
(100 U/mL; Biowhittaker, UK) were maintained. At conﬂuence, cells
were harvested as per sub-culture protocols and resuspended to desired
cell density.
The luciferase-reporting T. gondii RH strain 2F (ATCC® 50,839),
expressing β-galactosidase, was used for this study. The parasite was
maintained by repeated passages in human foreskin ﬁbroblast (HFF;
ATCC® SCRC-1041) cells cultured in DMEM supplemented with
GlutaMAX™-I, 10% (v/v) FCS; and penicillin and streptomycin. In order
to obtain parasite suspension, host cells infected with T. gondii tachy-
zoites were passed through a 27-guage needle to lyse them and the cell
lysates were then ﬁltered through a 5-μm ﬁlter to obtain a tachyzoite
suspension free of host cell debris. The suspension was washed with
fresh culture medium. Parasite density was determined with a hemo-
cytometer and adjusted for in vitro experimental infection analysis at a
multiplicity of infection (MOI) of 0.5.
2.4. Apoptosis assay
Cellular apoptosis was detected and measured with Apoptosis Assay
Cell-APOPercentage™ reagent (Biocolor Life Science Assays, Antrim,
UK) by following the manufacturer's protocol. Brieﬂy, growing HFF
Fig. 3. Cellular apoptosis after 24 h treatment with nanoparticles (NPs) or amino-nanoparticles (amino-NPs); [A] Without Toxoplasma gondii infection [B] With
Toxoplasma gondii infection. Data are presented as mean of triplicates± standard error of mean (SEM). The experiment was performed in triplicate and repeated
three times independently. α is signiﬁcant at p < .05 and γ at p < 0.0001versus negative control and/or infection only.
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cells in 96-well plates with or without T. gondii infection were treated
with the various nanoparticles (AgNP, AuNP, PtNP, AgNPTRP and
AuNPTRP) alone or in combination with small molecules as metabolic
modulators (anti-metabolites). The cells were then incubated for dif-
ferent time points at 37 °C and 5% CO2. Thereafter, cellular apoptosis
was monitored by colorimetric measurement recorded at 550 nm on a
microplate reader (MTP 500; Corona Electric, Hitachinaka Japan). The
biological assay was repeated three times, in triplicate. Selection of
doses for the nanoparticles as well as for small molecules was premised
on our earlier reports (Adeyemi et al., 2017a, 2017b, 2018b) and on
preliminary experiments. In all the cases, doses were less than one third
of the IC50 value.
2.5. Statistical analysis
Data were analyzed by using a one-way ANOVA (GraphPad
Software Inc., San Diego, CA) and are presented as the mean ±
standard error of the mean (SEM). Comparisons among groups were
determined by using Dunnett's post-hoc test. P-values< .05 were con-
sidered to be statistically signiﬁcant.
3. Results
AuNP at 5 μg/mL caused cellular apoptosis while AgNP led to a dose
dependent apoptosis (Fig. 1a). Likewise, AuNPTRP caused a dose-de-
pendent apoptosis but AgNPTRP only caused cellular apoptosis at the
highest dose (Fig. 1b). Meanwhile, addition of trolox appears to mildly
mitigate cellular apoptosis by the NPs and amino-NPs (Fig. 1c-d). The
cellular apoptosis caused by NPs and amino-NPs do not appear to follow
a deﬁnite pattern with time kinetics (Fig. 2a-f). Cellular apoptosis by
NPs and amino-NPs peaked within 24 h and further extension of in-
cubation time to 48 and 72 h showed no appreciable but inconsistent
increase in level of apoptosis.
In order to determine whether, cellular apoptosis by NPs and amino-
NPs was susceptible to modulation by T. gondii infection, we treated
infected cells with various concentrations of NPs and amino-NPs and
cellular apoptosis was determined after 24 h. T. gondii infection failed to
avert cellular apoptosis by NPs and amino-NPs (Fig. 3a-d). Meanwhile,
T. gondii infection alone did not cause cellular apoptosis after 24 h.
Furthermore, T. gondii and NPs have been shown to aﬀect similar
cellular targets (Adeyemi et al., 2017a, 2017b), therefore, we used
small molecules as metabolic modulators (anti-metabolites) of these
cellular targets to evaluate how cellular apoptosis by NPs and amino-
NPs would be impacted. The various anti-metabolites used in the pre-
sent study did not cause cellular apoptosis at doses investigated
(Fig. 4a). However, in order to validate our apoptosis detection assay,
we included staurosporine as a positive drug control. As expected
staurosporine caused cellular apoptosis thus validating our detection
assay. Of the metabolic modulators investigated in this study, none
modulated cellular apoptosis by amino-NPs (Fig. 4b-d and Fig. 5a). But
trolox (antioxidant), CoCl2 (chemical inducer of hypoxia) and YC-1
(inhibitor of HIF-1α) mildly modulated cellular apoptosis by NPs
(Fig. 5b-d). That these metabolic modulators modulate cellular apop-
tosis by NPs may indicate the relevance of these metabolic processes to
the apoptotic action of NPs.
Fig. 4. Cellular apoptosis after 24 treatment; [A] Metabolic modulators only [B] Nanoparticles (NPs) or amino-nanoparticles (amino-NPs) plus L-tryptophan [C]
Nanoparticles (NPs) or amino-nanoparticles (amino-NPs) plus 1-Methyl-D-tryptophan (DMT) [D] Nanoparticles (NPs) or amino-nanoparticles (amino-NPs) plus
naphthoquinone derivative (NPQ). Data are presented as mean of triplicates± standard error of mean (SEM). The experiment was performed in triplicate and
repeated three times independently.
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4. Discussion
Our current understanding of cellular interactions by NPs is limited.
This is because nanomedicine is still an emerging ﬁeld. Therefore, in
this study, we sought to determine the eﬀect of T. gondii infection and/
or various anti-metabolites on cellular apoptosis by NPs. The NPs
(AgNP) and amino-NPs (AuNPTRP) caused cellular apoptosis which
appeared to be dose-dependent but do not follow time kinetics.
Conversely, cellular apoptosis by AuNP and AgNPTRP was not dose-
dependent. Taken together, these ﬁndings are consistent with existing
ﬁndings that have demonstrated the apoptotic action of NPs (Azizi
et al., 2017; Moses et al., 2016). Interestingly, the NPs and amino-NPs
at the sub-cytotoxicity doses used in this study facilitated cellular
apoptosis. This ﬁnding conﬁrms earlier report which showed that NPs
can increase cellular susceptibility to cell death without necessarily
causing cytotoxicity (Leite et al., 2015). The PtNPs exhibited poor
cellular apoptosis possibly due to the fact that PtNPs have anti-oxida-
tive stress properties similar to those of cellular antioxidant enzymes
(Adeyemi et al., 2018a). Nevertheless, studies have demonstrated in
vitro apoptotic tendency of PtNPs in cancer cells, human ﬁbroblast as
well as in bacteria cells (Bendale et al., 2017; Kutwin et al., 2017;
bacterial cells and HFF cells (Nejdl et al., 2017).
Meanwhile, in the presence of T. gondii infection, cellular apoptosis
by NPs and amino-NPs was not mitigated. This ﬁnding may not only
indicate that cellular apoptosis by NPs and amino-NPs was not sus-
ceptible to modulation by T. gondii infection but that NPs and amino-
NPs have antagonistic impact against anti-apoptotic tendency of T.
gondii. The T. gondii infection has been reported to inhibit pro-apoptotic
cellular process, in order to ensure their replication and survival (Hippe
et al., 2009). T. gondii does this by aﬀecting the apoptotic cascade at
multiple levels; the inhibition of pro-apoptotic eﬀector proteins like Bax
and Bak, the avoidance of caspase 9 and Apaf-1 binding thus preventing
caspase 3/7 cascade, upsetting pro- and anti-apoptotic balance of BCL-2
proteins, impeding the function of poly(ADP-ribose) polymerase ex-
pression, and upregulating NF-κB pathway by GRA15, which depresses
the host immune system through interleukin 12, thereby preventing
apoptosis (Hippe et al., 2009; Besteiro, 2015; Kim et al., 2006; Begum-
Haque et al., 2009; Goebel et al., 2001). Thus, it is plausible that NPs
and amino-NPs are antagonist in one or more of these same apoptosis
eﬀector sites that are targets of T. gondii. This ﬁnding supports further
the prospects of NPs as alternative anti-parasite therapy.
Small molecules used in this study showed marginal apoptotic fea-
tures when compared with control as the majority of these anti-meta-
bolites failed to interfere with apoptotic potential of NPs and amino-
NPs. For example, trolox mildly modulated the apoptotic potential of
NPs. Trolox basically functions by mopping up ROS in the cell, thus our
ﬁnding conﬁrmed previous studies that showed oxidative stress as one
of the cytotoxic mechanisms of NPs (Bagherzadeh Homaee and
Ehsanpour, 2016; Mateo et al., 2013). This further suggests the culp-
ability of oxidative stress in the apoptotic action of NPs. That trolox
modulated cellular apoptosis by NPs may also indicate that cellular
reactivity of these NPs diﬀer from that of amino-NPs. In addition,
chemical induction of hypoxia by use of CoCl2 also modulated cellular
apoptosis by NPs. It's probable that hypoxia might be interfering with
the apoptotic action of NPs. This is further supported by mild mitigation
of YC-1 on cellular apoptosis by NPs. More so, NPs have capacity to
reduce HIF-1α activity (Adeyemi et al., 2017b; Yang et al., 2016) and
thus avert hypoxia. Therefore, it is plausible that capacity of NPs to
downregulate HIF-1α protein level might be connected to their apop-
totic tendency. Taken together, the ﬁndings do not only indicate that
these metabolic processes (oxidative stress and hypoxia) are relevant to
the apoptotic action of NPs but underscore variance in the cellular in-
teractions leading to apoptosis by both NPs and amino-NPs. Data herein
support that cellular apoptosis by NPs do not preclude oxidative stress
and hypoxia. This is not same for the amino-NPs (AgNPTRP and
AuNPTRP). The reason for this variance behavior in cellular apoptosis
Fig. 5. Cellular apoptosis after 24 treatment with nanoparticles (NPs) or amino-nanoparticles (amino-NPs) plus; [A] 1400W (inhibitor of nitric oxide synthase) [B]
Trolox [C] CoCl2 (chemical inducer of hypoxia) [D] YC-1 (inhibitor of HIF-1α protein). Data are presented as mean of triplicates± standard error of mean (SEM). The
experiment was performed in triplicate and repeated three times independently.
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induction by NPs and amino-NPs is not known yet but may be attrib-
uted to change in surface chemistry of amino-NPs occasioned by con-
jugation of l-tryptophan. This line of thought is consistent with our
earlier ﬁndings (Adeyemi et al., 2018b) in which NPs-tryptophan con-
jugates and NPs lacking this amino acid exhibited dissimilar cellular
interactions. Furthermore, NPs and amino-NPs have demonstrated ca-
pacity to activate kynurenine pathway in vitro (Adeyemi et al., 2017b)
by yet unknown mechanism. But in the present study, addition of l-
tryptophan to the culture medium failed to ameliorate cellular apop-
tosis by NPs and amino-NPs. This may indicate that apoptosis by NPs
and amino-NPs precludes activation of kynurenine pathway. Moreover,
competitive and non-competitive inhibitors of IDO-1 (a rate limiting
enzyme in the oxidative degradation of tryptophan to form kynurenine)
failed to assuage cellular apoptosis by NPs and amino-NPs.
In conclusion, the present study demonstrates the apoptotic poten-
tial of inorganic NPs and amino-NPs of Ag and Au. Further, our ﬁndings
are evidence supporting that apoptosis by NPs and amino-NPs was not
susceptible to modulation by T. gondii infection, thus supporting further
the prospects of NPs as alternative anti-parasitic agents. Additionally,
oxidative stress and chemical hypoxia are partly among the cellular
interactions leading to apoptosis caused by NPs. Considered together,
the data do not only glean new perspective to deepen our under-
standing of cellular interactions by NPs and amino-NPs but warrant
further investigations in order to fully comprehend mechanistic beha-
vior of NPs.
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